A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome

Clinical trial NCT06696261 · RECRUITING

Trial details

NCT number: NCT06696261
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Postprandial Distress Syndrome

Start date: 2025-02-27
Primary completion: 2026-12-31
Enrollment: 342

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.